Dysregulation of noncoding RNA in chordoma; implications in identifying potential targets for novel therapeutic approaches
Authors:
- 18 January 2024
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-17
Abstract
Chordoma is a rare form of bone cancer develops in the spinal cord and skull. Instead of conventional (radio/chemotherapies) and targeted therapies, the disease is associated with high rate of recurrence and poor patient survival. Thus, for better disease management, the molecular pathogenesis of chordoma should be studied in detail to identify dysregulated biomolecules that can be targeted by novel therapeutics. Recent research showed frequent dysregulation of long noncoding RNA (lncRNA), microRNA (miRNA), and circular RNA (circRNA) in association with aggressive tumor phenotypes like cell proliferation, migration, invasion, and metastasis in a variety of cancers, including chordoma. Apart from diagnostic and prognostic importance, noncoding RNAs may serve as promising targets for novel therapeutics in cancer. In this review, we summarized a list of miRNAs, lncRNAs, and circRNA found to be dysregulated in chordoma from available data published in relevant databases (PubMed), as such an approach seems to be rare to date. The dysregulated noncoding RNAs were also associated with adverse tumor phenotypes to assess the impact on disease pathogenesis and, associated downstream molecular pathways were focused. Synthetic compounds and natural products that were reported to target the noncoding RNAs in other malignancies were also listed from published literature and proposed as potential therapeutic agents in chordoma. This review will provide information for further research on chordoma focusing on detailed characterization of dysregulated lncRNAs, miRNAs, and circRNA to understand the disease pathogenesis and, exploration of suitable natural and synthetic products targeting dysregulated non-coding RNAs to develop effective therapeutic measures.Keywords
Funding Information
- West Bengal State Government, India (FRPDF)
This publication has 104 references indexed in Scilit:
- Integrated miRNA-mRNA Analysis Revealing the Potential Roles of miRNAs in ChordomasPLOS ONE, 2013
- Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate CancerPLOS ONE, 2013
- Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cellsBrain Research, 2012
- Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAsOncogene, 2012
- Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation TreatmentPLOS ONE, 2011
- p16INK4Aand p14ARFTumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid TumorsJournal of Neuropathology & Experimental Neurology, 2011
- Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic CancerPLOS ONE, 2011
- Chordoma: clinical characteristics, management and prognosis of a case series of 25 patientsBMC Cancer, 2010
- Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cellsInternational Journal of Molecular Medicine, 2009
- New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sitesGenome Research, 2009